Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review

키워드

참고문헌 (100)

1. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues" (2017), IARC Press
2. Shankland KR, "Non-Hodgkin lymphoma", Lancet, 380, pp.848~857 (2012)
3. Ahmed S, "Orbital lymphomas : a clinicopathologic study of a rare disease", Am J Med Sci, 331, pp.79~83 (2006)
4. Demirci H, "Orbital tumors in the older adult population", Ophthalmology, 109, pp.243~248 (2002)
5. Margo CE, "Malignant tumors of the orbit : analysis of the Florida Cancer Registry", Ophthalmology, 105, pp.185~190 (1998)
6. Isaacson P, "Malignant lymphoma of mucosa-associated lymphoid tissue : a distinctive type of B-cell lymphoma", Cancer, 52, pp.1410~1416 (1983)
7. Rosado MF, "Ocular adnexal lymphoma : a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci", Blood, 107, pp.467~472 (2006)
8. Akpek EK, "Conjunctival lymphoma masquerading as chronic conjunctivitis", Ophthalmology, 106, pp.757~760 (1999)
9. Bhatia S, "Curative radiotherapy for primary orbital lymphoma", Int J Radiat Oncol Biol Phys, 54, pp.818~823 (2002)
10. Martinet S, "Outcome and prognostic factors in orbital lymphoma : a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy", Int J Radiat Oncol Biol Phys, 55, pp.892~898 (2003)
11. Olsen TG, "Orbital lymphoma", Surv Ophthalmol, 64, pp.45~66 (2019)
12. Uno T, "Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa : a multiinstitutional, retrospective review of 50 patients", Cancer, 98, pp.865~871 (2003)
13. Sjö LD, "Ophthalmic lymphoma : epidemiology and pathogenesis", Acta Ophthalmol, 87(Thesis 1), pp.1~20 (2009)
14. van der Gaag R, "Immunological responses in the eyelid and orbit", Eye(Lond), 2(Pt 2), pp.158~163 (1988)
15. Du MQ, "Gastric MALT lymphoma : from aetiology to treatment", Lancet Oncol, 3, pp.97~104 (2002)
16. Ferreri AJ, "Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas", J Natl Cancer Inst, 96, pp.586~594 (2004)
17. Byrne GI, "Chlamydia and apoptosis : life and death decisions of an intracellular pathogen", Nat Rev Microbiol, 2, pp.802~808 (2004)
18. Collina F, "Chlamydia psittaci in ocular adnexa MALT lymphoma : a possible role in lymphomagenesis and a different geographical distribution", Infect Agent Cancer, 7, pp.8~ (2012)
19. Chanudet E, "Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions", J Pathol, 209, pp.344~351 (2006)
20. Coupland SE, "Molecular pathology of lymphoma", Eye(Lond), 27, pp.180~189 (2013)
21. Daibata M, "Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients", Br J Haematol, 132, pp.651~652 (2006)
22. Mulder MM, "No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands", Leuk Res, 30, pp.1305~1307 (2006)
23. Vargas RL, "Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? : the University of Rochester experience", Leuk Res, 30, pp.547~551 (2006)
24. Bayraktar S, "Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma(MALT) : single institution experience in a large cohort of patients", Br J Haematol, 152, pp.72~80 (2011)
25. Bernardini FP, "Lymphoproliferative disease of the orbit", Curr Opin Ophthalmol, 18, pp.398~401 (2007)
26. Ferreri AJ, "Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma : final results of an international phase II trial", J Clin Oncol, 30, pp.2988~2994 (2012)
27. Ferreri AJ, "Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma : a multicenter prospective trial", J Natl Cancer Inst, 98, pp.1375~1382 (2006)
28. Ferreri AJ, "Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa", Ann Oncol, 17, pp.769~772 (2006)
29. Fischbach W, "Gastric MALT lymphoma : update on diagnosis and treatment", Best Pract Res Clin Gastroenterol, 28, pp.1069~1077 (2014)
30. Achenbach CJ, "Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy", AIDS, 25, pp.691~700 (2011)
31. Riedel DJ, "HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population", Leuk Lymphoma, 57, pp.306~312 (2016)
32. Bruyand M, "Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era : Agence Nationale de Recherche sur le Sida(ANRS)CO3 Aquitaine Cohort", Clin Infect Dis, 49, pp.1109~1116 (2009)
33. Guiguet M, "Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies(FHDH-ANRS CO4) : a prospective cohort study", Lancet Oncol, 10, pp.1152~1159 (2009)
34. Zoufaly A, "Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma", J Infect Dis, 200, pp.79~87 (2009)
35. Teixeira Mendes LS, "Marginal zone lymphoma : associated autoimmunity and auto-immune disorders", Best Pract Res Clin Haematol, 30, pp.65~76 (2017)
36. Zintzaras E, "The risk of lymphoma development in autoimmune diseases : a meta-analysis", Arch Intern Med, 165, pp.2337~2344 (2005)
37. Du MQ, "MALT lymphoma : many roads lead to nuclear factor-κb activation", Histopathology, 58, pp.26~38 (2011)
38. Ruiz A, "Extranodal marginal zone B-cell lymphomas of the ocular adnexa : multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci", Am J Surg Pathol, 31, pp.792~802 (2007)
39. Tanimoto K, "Fluorescence in situ hybridization(FISH)analysis of primary ocular adnexal MALT lymphoma", BMC Cancer, 6, pp.249~ (2006)
40. Priego G, "Orbital lymphoma : imaging features and differential diagnosis", Insights Imaging, 3, pp.337~344 (2012)
41. Eissa L, "Arterial spin labeling and diffusion-weighted MR imaging : utility in differentiating idiopathic orbital inflammatory pseudotumor from orbital lymphoma", Clin Imaging, 71, pp.63~68 (2021)
42. Politi LS, "Ocular adnexal lymphoma : diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring", Radiology, 256, pp.565~574 (2010)
43. Isaacson PG, "Extranodal lymphomas" (1996), Churchill Livingstone
44. Mannami T, "Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders : characterization of malt lymphoma and reactive lymphoid hyperplasia", Mod Pathol, 14, pp.641~649 (2001)
45. Kremer M, "PCR analysis of IgH-gene rearrangements in small lymphoid infiltrates microdissected from sections of paraffin-embedded bone marrow biopsy specimens", Hum Pathol, 31, pp.847~853 (2000)
46. Adachi A, "No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma", Pathol Int, 54, pp.16~25 (2004)
47. Coupland SE, "Lymphomas involving the eye and the ocular adnexa", Curr Opin Ophthalmol, 17, pp.523~531 (2006)
48. Coupland SE, "Prognostic value of cell-cycle markers in ocular adnexal lymphoma : an assessment of 230 cases", Graefes Arch Clin Exp Ophthalmol, 242, pp.130~145 (2004)
49. Coupland SE, "Lymphoproliferative lesions of the ocular adnexa : analysis of 112 cases", Ophthalmology, 105, pp.1430~1441 (1998)
50. Ferreri AJ, "Ocular adnexal MALT lymphoma : an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy", Ann Oncol, 19, pp.835~846 (2008)
51. Franco R, "Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival", Mod Pathol, 19, pp.1055~1067 (2006)
52. Bouali S, "Primary sporadic Burkitt lymphoma of the orbit, clinical characteristics, management, and outcomes : a case study", Childs Nerv Syst, 32, pp.437~440 (2016)
53. Rasmussen P, "Mantle cell lymphoma in the orbital and adnexal region", Br J Ophthalmol, 93, pp.1047~1051 (2009)
54. Armitage JO, "Staging non-Hodgkin lymphoma", CA Cancer J Clin, 55, pp.368~376 (2005)
55. Carbone PP, "Report of the Committee on Hodgkin’s Disease Staging Classification", Cancer Res, 31, pp.1860~1861 (1971)
56. Coupland SE, "A TNM-based clinical staging system of ocular adnexal lymphomas", Arch Pathol Lab Med, 133, pp.1262~1267 (2009)
57. Rosenberg SA, "Report of the Committee on Hodgkin’s Disease Staging Procedures", Cancer Res, 31, pp.1862~1863 (1971)
58. Graue GF, "Ocular adnexal lymphoma staging and treatment : American Joint Committee on Cancer versus Ann Arbor", Eur J Ophthalmol, 23, pp.344~355 (2013)
59. Lee SE, "Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue(MALT lymphoma)", Am J Hematol, 86, pp.262~266 (2011)
60. Amin MB, "AJCC cancer staging manual" (2017), Springer
61. Tanimoto K, "Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma", Ann Oncol, 17, pp.135~140 (2006)
62. Cohen VM, "Treatment options for ocular adnexal lymphoma(OAL)", Clin Ophthalmol, 3, pp.689~692 (2009)
63. Fung CY, "Ocular adnexal lymphoma : clinical behavior of distinct World Health Organization classification subtypes", Int J Radiat Oncol Biol Phys, 57, pp.1382~1391 (2003)
64. Bolek TW, "Radiotherapy in the management of orbital lymphoma", Int J Radiat Oncol Biol Phys, 44, pp.31~36 (1999)
65. Goda JS, "Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy : efficacy and toxicity", Int J Radiat Oncol Biol Phys, 81, pp.e659~e666 (2011)
66. Stafford SL, "Orbital lymphoma : radiotherapy outcome and complications", Radiother Oncol, 59, pp.139~144 (2001)
67. Yen MT, "Treatments for ocular adnexal lymphoma : a report by the American Academy of Ophthalmology", Ophthalmology, 125, pp.127~136 (2018)
68. Fasola CE, "Low-dose radiation therapy(2 Gy × 2)in the treatment of orbital lymphoma", Int J Radiat Oncol Biol Phys, 86, pp.930~935 (2013)
69. Pinnix CC, "Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma", Head Neck, 39, pp.1095~1100 (2017)
70. Ben Simon GJ, "Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit", Ophthalmology, 113, pp.1209~1213 (2006)
71. Jäger G, "Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine : 6 year follow-up of a phase II trial", Ann Oncol, 17, pp.1722~1723 (2006)
72. Raderer M, "Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma", J Clin Oncol, 23, pp.8442~8446 (2005)
73. Zinzani PL, "Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma", Cancer, 100, pp.2190~2194 (2004)
74. Kim JS, "Clinical outcome of eradication therapy for gastric mucosa-associated lymphoid tissue lymphoma according to H. pylori infection status", Gastroenterol Res Pract, 2016, pp.6794848~ (2016)
75. Isaacson PG, "MALT lymphoma : from morphology to molecules", Nat Rev Cancer, 4, pp.644~653 (2004)
76. Wotherspoon AC, "Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma", Lancet, 338, pp.1175~1176 (1991)
77. Yoo C, "Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea", Am J Hematol, 82, pp.821~823 (2007)
78. Liu YC, "Chlamydia psittaci in ocular adnexal lymphoma : Japanese experience", Leuk Res, 30, pp.1587~1589 (2006)
79. de Cremoux P, "Re : Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas", J Natl Cancer Inst, 98, pp.365~366 (2006)
80. Gracia E, "Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients", Leuk Lymphoma, 48, pp.104~108 (2007)
81. Zhang GS, "Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma", Leuk Lymphoma, 48, pp.577~583 (2007)
82. Han JJ, "Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma", Ann Hematol, 94, pp.575~581 (2015)
83. Grünberger B, "‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa", Ann Oncol, 17, pp.484~487 (2006)
84. Tuncer S, "Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma : single institution experience", Curr Eye Res, 40, pp.780~785 (2015)
85. Riley JK, "CD20 : a gene in search of a function", Semin Oncol, 27(6 Suppl 12), pp.17~24 (2000)
86. Annibali O, "Rituximab as single agent in primary MALT lymphoma of the ocular adnexa", Biomed Res Int, 2015, pp.895105~ (2015)
87. Ferreri AJ, "Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa", Haematologica, 90, pp.1578~1579 (2005)
88. Rigacci L, "Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas", Ann Hematol, 86, pp.565~568 (2007)
89. Knudsen MK, "Clinicopathological features of ocular adnexal mantle-cell lymphoma in an international multicenter cohort", JAMA Ophthalmol, 135, pp.1367~1374 (2017)
90. Rasmussen PK, "Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland : an investigation of clinical and histopathological features", Acta Ophthalmol, 91(Thesis 5), pp.1~27 (2013)
91. Blasi MA, "Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma : a preliminary report", Ophthalmology, 108, pp.559~562 (2001)
92. Blasi MA, "Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma : long-term results", Ophthalmology, 119, pp.494~500 (2012)
93. Lachapelle KR, "Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b", Arch Ophthalmol, 118, pp.284~285 (2000)
94. Jenkins C, "Histological features of ocular adnexal lymphoma(REAL classification)and their association with patient morbidity and survival", Br J Ophthalmol, 84, pp.907~913 (2000)
95. McKelvie PA, "Ocular adnexal lymphoproliferative disease : a series of 73 cases", Clin Exp Ophthalmol, 29, pp.387~393 (2001)
96. Sullivan TJ, "Lymphoproliferative disease of the ocular adnexa : a clinical and pathologic study with statistical analysis of 69 patients", Ophthalmic Plast Reconstr Surg, 21, pp.177~188 (2005)
97. Jenkins C, "Clinical features associated with survival of patients with lymphoma of the ocular adnexa", Eye(Lond), 17, pp.809~820 (2003)
98. Moslehi R, "Rapidly increasing incidence of ocular non-hodgkin lymphoma", J Natl Cancer Inst, 98, pp.936~939 (2006)
99. Cho EY, "Clinicopathologic analysis of ocular adnexal lymphomas : extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients", Am J Hematol, 73, pp.87~96 (2003)
100. Lee JL, "Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa", Ann Hematol, 84, pp.13~18 (2005)

관련 논문AI추천